Brazil and Japan sign health cooperation agreement

11 August 2014
shaking-hands-big

Brazil's Ministry of Health has signed a memorandum of global cooperation with the government of Japan, writes Juliane Carvalho of Brazil Pharma News.

The goal is to strengthen relations with Japan, bringing positive results for both countries. The agreement covers the areas of regulation, pharmaceutical knowledge and experience sharing about public health systems. The deal between Japan and Brazil aims to develop policies and strategies for health promotion with a focus on the aging populations and the strengthening of human resources in health. The memorandum is part of a comprehensive cooperation signed on August 1 between the two countries, which includes treaties in other areas.

In the field of health promotion with a focus on the aging population, the dialogue between the governments of Brazil and Japan predicts future partnerships. The two countries also intend to carry out joint projects with the goal of promoting healthy lifestyle and disease prevention. Brazil's Health Minister, Arthur Chioro, said: "The process of cooperation between Brazil and Japan can provide many benefits for both nations.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight



More Features in Pharmaceutical